Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

MEDRAD, Inc., has signed a distribution and co-marketing partnership agreement with PETNet Solutions to enable health care providers to inject fluorodeoxyglucose for PET/CT imaging procedures in a new way.

MEDRAD, Inc., has signed a distribution and co-marketing partnership agreement with PETNet Solutions, a fully owned subsidiary of Siemens Medical Solutions USA, Inc. The agreement will enable health care providers to inject fluorodeoxyglucose (FDG) for positron emission tomography/computed tomography (PET/CT) imaging procedures in an innovative, new way. The partnership will leverage Medrad's soon to be introduced PET infusion system and multi-dose FDG packaging and delivery from PETNet Solutions.

MEDRAD's PET infusion system, to be called Intego™, is designed to automatically extract a patient dose from a multi-dose vial and deliver it directly to the patient. The system is mobile and includes dosimetry, shielding, and a touchscreen interface - all with precision, flexibility, and safety in mind.

PETNet Solutions has agreed to provide FDG to customers throughout its extensive, cyclotron-based radiopharmacy network in multi-dose vials and specially designed vial shields, which will allow for easy integration with Medrad's new system.

Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Medical Solutions USA, Inc., commented, "In addition to our traditional delivery method, by providing FDG in multi-dose vials compatible with the Medrad PET infusion system across our extensive network, we have the opportunity to help improve the way FDG is being handled and delivered."

Alan Connor, director of global marketing for Medrad Molecular Imaging, said, "We are very pleased that PETNet Solutions is the first FDG provider to agree to provide FDG in a manner compatible with the Intego System across its entire network. From the beginning of this project, PETNet Solutions has been instrumental to the development of this system and is dedicated to providing the latest in safety and clinical performance to their customers."